Is Helicobacter pylori associated with Behçet's syndrome? A meta-analysis

Ye Yu1, Xin Yao2, Junyu Liang1

  • 1Division of Rheumatology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.

Helicobacter
|October 17, 2019
PubMed

Insights

Behçet's syndrome patients have a higher rate of Helicobacter pylori infection. Eradicating H. pylori can improve symptoms like oral and genital ulcers, suggesting a potential causal link.

Area of Science:

  • Gastroenterology
  • Immunology
  • Infectious Diseases

Background:

  • Controversy exists regarding the association between Helicobacter pylori (H. pylori) infection and Behçet's syndrome (BS).
  • Previous studies have explored this relationship, necessitating further clarification.

Purpose of the Study:

  • To conduct a meta-analysis to elucidate the relationship between H. pylori infection and BS.
  • To determine if H. pylori eradication impacts BS clinical manifestations.

Main Methods:

  • A systematic literature search was performed in PubMed, MEDLINE, and Embase up to July 1, 2019.
  • Six relevant English-language studies were included based on predefined criteria.
  • Statistical data were extracted and analyzed to assess the association and treatment effects.

Main Results:

  • Behçet's syndrome patients demonstrated a 1.39-fold increased susceptibility to H. pylori infection.
  • Significant improvements were observed in oral ulceration, genital ulceration, and cutaneous lesions following H. pylori eradication.
  • Publication bias and sensitivity analyses confirmed the statistical robustness of the findings, indicating no significant heterogeneity.

Conclusions:

  • Behçet's syndrome patients exhibit a higher prevalence of H. pylori infection.
  • H. pylori eradication is associated with the improvement of key clinical symptoms in BS patients.
  • These findings suggest H. pylori may play an etiological role in the development of Behçet's syndrome.
Abstract

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.0K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
497
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
700
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.1K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.0K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.1K